Prognostic significance of cathepsin‐D expression in node‐positive breast carcinoma: An immunohistochemical study
Authors:
- 30 September 1993
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 55 (3) , 429-435
Abstract
The prognostic significance of cathepsin‐D expression was evaluated by immunohistochemistry in 638 node‐positive breast carcinomas diagnosed between 1980 and 1986. A minimum of 2.5 years of follow‐up was available for each patient (maximum: 9.5 years). Cathepsin‐D expression was assessed separately both in cancer and in stromal cells using a commercially available polyclonal antibody. While cancer‐cell immunostaining was not associated with prognosis, positive staining of stromal elements was related to shorter metastasis‐free survival. The difference in distant metastasis‐free survival between positive and negative expressors was greatest in the sub‐group of patients submitted to adjuvant chemotherapy, with a hazard ratio for occurrence of distant metastasis of 1.76 by multivariate analysis, but was lowest for those receiving hormone therapy. Cathepsin‐D expression by stromal cells was related to HER‐2/ neu oncoprotein expression, HSP‐27 expression, poor nuclear grade, aneuploidy, and absence of estrogen and progesterone receptors. No association was found with the number of involved lymph nodes, tumor size, age, histologic grade, S‐phase fraction, or vascular invasion. Our study suggests that cathepsin‐D expression by stromal cells (and not by cancer cells) affects the prognosis of breast cancer, that stromal cells probably play a key role in local invasion and metastatic dissemination of the tumor, and that the prognostic significance of cathepsin‐D expression may vary according to the type of adjuvant therapy.Keywords
This publication has 21 references indexed in Scilit:
- Prognostic Factors and Treatment Decisions in Axillary-Node-Negative Breast CancerNew England Journal of Medicine, 1992
- Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancersEuropean Journal of Cancer and Clinical Oncology, 1991
- Stress Response Protein (srp-27) Determination in Primary Human Breast Carcinomas: Clinical, Histologic, and Prognostic CorrelationsJNCI: Journal of the National Cancer Institute, 1991
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990
- Cathepsin D in breast cancerBreast Cancer Research and Treatment, 1990
- Cathepsin D assay in primary breast cancer and lymph nodes: Relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasivenessEuropean Journal of Cancer, 1990
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958